SCHEMBL7364507

SCHEMBL7364507

CN(C)c1ccc(CNC(=O)CCCCCCC(=O)C(F)(F)F)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 10/20 0.60
HDAC2 Q92769 10/20 0.60
HDAC10 Q969S8 10/20 0.60
HDAC8 Q9BY41 10/20 0.60
HDAC6 Q9UBN7 10/20 0.60
HDAC3 O15379 9/20 0.60
HDAC11 Q96DB2 9/20 0.60
HDAC4 P56524 8/20 0.60
HDAC7 Q8WUI4 8/20 0.60
HDAC9 Q9UKV0 8/20 0.60
HDAC5 Q9UQL6 8/20 0.60
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
LMNA P02545 1/20 0.49
EPHX2 P34913 1/20 0.48
HPGD P15428 1/20 0.48
FAAH O00519 1/20 0.48
NCOR1 O75376 1/20 0.47
GLS O94925 1/20 0.47
KDM4E B2RXH2 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7364362 0.83 LMNA (0.71) HDAC1HDAC2HDAC10HDAC8HDAC6
SCHEMBL7371613 0.82 HDAC3 (0.56) HDAC1HDAC2HDAC10HDAC8HDAC6
SCHEMBL7368390 0.82 HDAC3 (0.56) HDAC1HDAC2HDAC10HDAC8HDAC6
SCHEMBL7368984 0.82 MEN1 (0.76) HDAC1HDAC2HDAC10HDAC8HDAC6
SCHEMBL7371165 0.82 CNR1 (0.62) HDAC1HDAC2HDAC10HDAC8HDAC6
SCHEMBL7373555 0.81 HDAC1 (0.68) HDAC1HDAC2HDAC10HDAC8HDAC6
SCHEMBL13716200 0.81 HDAC1 (0.60) HDAC1HDAC2HDAC10HDAC8HDAC6
SCHEMBL7365700 0.76 TRPV1 (0.61) HDAC1HDAC2HDAC10HDAC8HDAC6
SCHEMBL10113602 0.75 HDAC1 (0.57) HDAC1HDAC2HDAC10HDAC8HDAC6
SCHEMBL10113877 0.75 HDAC1 (0.57) HDAC1HDAC2HDAC10HDAC8HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020103192-A1 Inhibitors of histone deacetylase ABBOTT LABORATORIES 2002-08-01 US claimed
US-20020177594-A1 Inhibitors of histone deacetylase ABBOTT LABORATORIES 2002-11-28 US disclosed
US-20020103192-A1 Inhibitors of histone deacetylase ABBOTT LABORATORIES 2002-08-01 US disclosed
WO-2002046129-A2 INHIBITORS OF HISTONE DEACETYLASE ABBOTT LABORATORIES (US) 2002-06-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020103192-A1 Inhibitors of histone deacetylase HDAC1, HDAC5, HDAC4 HDAC1 1/4885HDAC2 7/4885HDAC10 8/4885
US-20020177594-A1 Inhibitors of histone deacetylase HDAC1, HDAC11, HDAC3 HDAC1 1/4885HDAC2 4/4885HDAC10 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.